Source Pravda.Ru

Northstar Neuroscience’s stocks fall as clinical experiments fail - Comments

Northstar Neuroscience’s late-stage trial of its treatment to improve hand and arm function in stroke victims, did not provide any significant benefit over rehabilitation therapy. Its stocks dropped more than 83 percent.

Show more